Bioliberty

Series-A
bioliberty.com Biotech & Healthcare
Total Funding $13.8M
Latest Round $3.3M Series-A
Last Announced Nov 2, 2026
Investors Undisclosed
Decision Makers 6 Available

About Bioliberty

Supporting stroke and neurological rehabilitation with innovative technology that motivates patients and helps clinicians deliver effective therapy.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 2, 2026

Web & Domain Identity

Official Website bioliberty.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $3,300,000 · Series-A

    finsmes.com

  2. Capital Raise

    Raised $10,500,000 · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Bioliberty.

Funding History

2 Rounds
Series-A equity · Nov 2, 2026
$3,300,000 finsmes.com
Series-A equity · Mar 19, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts